Decreased proteins, not amyloid plaques, tied to Alzheimer's disease
sciencedaily.com
sciencedaily.com
"Interestingly, lecanemab, the anti-amyloid drug recently reported as beneficial, does something that most other anti-amyloid treatments don't do in addition to reducing amyloid: it increases the levels of the soluble amyloid-beta," Espay said.